Trial Profile
A phase Ib/IIa study of NBS-03 in patients with refractory asthma
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 27 Dec 2022
Price :
$35
*
At a glance
- Drugs NBS 03 (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 17 Jul 2014 New trial record